Back to Journals » Lung Cancer: Targets and Therapy

Lung Cancer: Targets and Therapy

ISSN: 1179-2728

An international, peer-reviewed, open access journal focusing on lung cancer research, identification of therapeutic targets and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival and quality of life for the cancer patient.

This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).

Latest articles:

- 5 records -

Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for HER2 Mutation Positive Non-Small Cell Lung Cancer

Azar I, Alkassis S, Fukui J, Alsawah F, Fedak K, Al Hallak MN, Sukari A, Nagasaka M

Lung Cancer: Targets and Therapy 2021, 12:103-114

Published Date: 7 October 2021

An Observational Study to Assess the Molecular Epidemiology and Direct Medical Costs of Epidermal Growth Factor Receptor (EGFR) Mutations in Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer Treated with Afatinib in Real-World Clinical Settings in Greece

Mountzios G, Lampaki S, Koliou GA, Vozikis A, Kontogiorgos I, Papantoniou P, Koufaki MI, Res E, Boutis A, Christopoulou A, Pastelli N, Grivas A, Aravantinos G, Lalla E, Oikonomopoulos G, Koumarianou A, Spyratos D, Bafaloukos Snr D, Rigakos G, Papakotoulas P, Fountzilas G, Linardou H

Lung Cancer: Targets and Therapy 2021, 12:93-102

Published Date: 30 August 2021

An Update on the Use of Exhaled Breath Analysis for the Early Detection of Lung Cancer

Peled N, Fuchs V, Kestenbaum EH, Oscar E, Bitran R

Lung Cancer: Targets and Therapy 2021, 12:81-92

Published Date: 16 August 2021

Targeting AXL in NSCLC

Zaman A, Bivona TG

Lung Cancer: Targets and Therapy 2021, 12:67-79

Published Date: 10 August 2021


Read more articles